Chronic paranoid and hallucinatory paranoidal conditions, psychomotor agitation in patients with schizophrenia (hallucinatory-delusional, hebephrenic and catatonic syndrome), alcohol-induced psychosis, maniacal agitation in patients with manic-depressive psychosis, mental disorders in patients with epilepsy, agitated depression in patients with presenile, manic-depressive psychosis, other diseases, accompanied by agitation, tension. Neurotic disorders accompanied by increased muscle tone. Permanent pain, including causalgia (concomitantly with analgetics), permanent sleep disorders (concomitantly with insomnia medications and ataractic agents). Meniere's disease, vomiting in pregnancy, preventing of vomiting during treatment with antitumor agents and radiation therapy. Dermatological itch. As a component of “lytic cocktail” in anesthesiology.

Treatment of arterial hypertension, chronic stable angina, vasospastic angina (Prinzmetal angina).

Amoxicillin is a semisynthetic representative of beta-lactams, which break the bacterial cell wall synthesis in the active growth phase and causes the death of microorganisms. The spectrum of activity of amoxicillin trihydreate in respect of gram-positive microorganisms include: Streptococcus spp., Enterococcus faecalis, Staphylococcus spp. (Except for strains producing beta-lactamase), Corynebacterium diphtheriae, Bacillus antracis, Clostridium spp., Listeria monocytogenes. The medicinal product is also active against gram negative (microorganisms (Neisseria gonorrhoeae, Neisseria meningitidis, Bordetella pertussis, some strains of Haemophilus influenzae, Escherichia coli, Shigella spp., Spp., etc.), as well as some spirochetes (Leptospira spp., Borrelia spp.). Amoxicillin is destroyed beta-lactamase. Acid resistance.

Respiratory infections, gastrointestinal infections, urinary tract infections, skin and soft tissue infections caused by drug-sensitive microorganisms. In combination with metronidazole or clarithromycin is used to treat gastrointestinal diseases caused by Helicobacter pylori infection.

Infections caused by susceptible to the drug microorganisms: respiratory; urogenital system; digestive tract; skin and soft tissues.

Treatment of bacterial infections caused by susceptible to the Amoxil-K microorganisms, such as severe infections of the throat, nose and ear (mastoiditis, peritonsillar infections, epiglottitis, and sinusitis associated with severe systemic signs and symptoms); exacerbation of chronic bronchitis (after confirmation of the diagnosis); community-acquired pneumonia; cystitis; pyelonephritis; infections of the skin and soft tissues, including bacterial cellulitis, animal bites, severe dentoalveolar abscesses with cellulitis spread; bone and joint infections, including osteomyelitis; intra-abdominal infections; genital infections in women. Prevention of bacterial infections in major surgery in the following areas: gastrointestinal tract; pelvic organs; head and neck; biliary tract.

Treatment of bacterial infections caused by susceptible to medicinal product microorganisms, such as acute bacterial sinusitis; acute otitis media; confirmed exacerbation of chronic bronchitis; community-acquired pneumonia; cystitis; pyelonephritis; infections of skin and soft tissues, including cellulitis, animal bites, severe dentoalveolar abscesses with advanced cellulite; bone and joint infections, including osteomyelitis.